Meth use fuels higher rates of unsafe sex, HIV risk in young men who have sex with men

August 01, 2011

A study by researchers at Johns Hopkins Children's Center and elsewhere shows that methamphetamine use can fuel HIV infection risk among teenage boys and young men who have sex with men (MSM), a group that includes openly gay and bisexual men, as well as those who have sex with men but do not identify themselves as gay or bisexual.

The researchers said that nearly one-third (20) of the 64 participants who reported recent meth use also reported sex with an HIV-infected person, while half reported sex with an injection drug user. More than half, 34, said they have had unprotected sex.

While previous research has linked risky sexual behaviors to drug use in MSM, the new study is the first multi-city analysis to also include teenagers, a group made especially vulnerable by lack of experience, the investigators say.

The team's findings, published in the Aug. 1 issue of the Archives of Pediatrics & Adolescent Medicine, underscore the need for HIV prevention programs to factor in the role of substance abuse, the investigators say.

"Drug use is closely linked to risk-taking behaviors, including sexually risky behaviors, so any HIV prevention efforts must, by definition, include drug use prevention and treatment of those with known drug problems," said senior investigator Jonathan Ellen, M.D., a pediatrician and adolescent health specialist at Johns Hopkins Children's Center.

Methamphetamine ¬ a popular and relatively cheap street drug ¬ heightens sexual response and lowers inhibitions, the researchers note.

"Add meth and you have a formula that leads to increased sexual risk in a group that already has higher prevalence of HIV," says study co-investigator Nancy Willard, M.S., a researcher at Johns Hopkins.

The NIH-funded asked 595 males, ages 12 to 24, from eight major U.S. cities, including New York City, Baltimore and Washington, D.C., to describe their use of methamphetamine, other hard drugs and their sexual behavior.

Overall, recent meth users were more likely than those with no recent drug use to have had sex with an HIV-positive person (33 percent vs. 11 percent), to have history of sexually transmitted infections (52 percent vs. 21 percent), to have had sex with an injection drug user (52 percent vs. 11 percent) and to have sex with multiple partners in the past three months (86 percent vs. 63 percent). Meth users were also more likely to report having unprotected sex than those without recent drug use (67 percent vs. 46 percent). And recent meth users were also more likely than those with no recent drug use to be or have been homeless (72 percent vs. 28 percent) and less likely to be enrolled in school (36 vs. 60 percent).

The researchers caution that any drug abuse ¬ not just methamphetamine ¬ can push up the rates of risky behavior. Indeed, participants who reported having used other hard drugs such as cocaine, crack, heroin and ecstasy, were more likely than non-drug users to have sex with HIV-infected partners (24 vs. 11 percent) and more likely to have sex with injection drug users (20 percent vs. 10 percent)
-end-
Researchers from other institutions included Peter Freeman, M.P.H., and Robert Garofalo, M.D., of Children's Memorial Hospital at Northwestern University, and Robert Harris, Ph.D., of Westat Inc.

Bendu Walker, M.P.H., also of Johns Hopkins, was co-author on the paper.

Related on the Web:

Higher HIV Risk in Black Gay Men Linked to Partner Choice, Risk Perception http://www.hopkinschildrens.org/Higher-HIV-Risk-in-Black-Gay-Men.aspx

STI, HIV Counseling Inadequate in Male Teens http://www.hopkinschildrens.org/newsDetail.aspx?id=8302&terms=Arik+Marcell

Johns Hopkins Medicine

Related HIV Articles from Brightsurf:

BEAT-HIV Delaney collaboratory issues recommendations measuring persistent HIV reservoirs
Spearheaded by Wistar scientists, top worldwide HIV researchers from the BEAT-HIV Martin Delaney Collaboratory to Cure HIV-1 Infection by Combination Immunotherapy (BEAT-HIV Collaboratory) compiled the first comprehensive set of recommendations on how to best measure the size of persistent HIV reservoirs during cure-directed clinical studies.

The Lancet HIV: Study suggests a second patient has been cured of HIV
A study of the second HIV patient to undergo successful stem cell transplantation from donors with a HIV-resistant gene, finds that there was no active viral infection in the patient's blood 30 months after they stopped anti-retroviral therapy, according to a case report published in The Lancet HIV journal and presented at CROI (Conference on Retroviruses and Opportunistic Infections).

Children with HIV score below HIV-negative peers in cognitive, motor function tests
Children who acquired HIV in utero or during birth or breastfeeding did not perform as well as their peers who do not have HIV on tests measuring cognitive ability, motor function and attention, according to a report published online today in Clinical Infectious Diseases.

Efforts to end the HIV epidemic must not ignore people already living with HIV
Efforts to prevent new HIV transmissions in the US must be accompanied by addressing HIV-associated comorbidities to improve the health of people already living with HIV, NIH experts assert in the third of a series of JAMA commentaries.

The Lancet HIV: Severe anti-LGBT legislations associated with lower testing and awareness of HIV in African countries
This first systematic review to investigate HIV testing, treatment and viral suppression in men who have sex with men in Africa finds that among the most recent studies (conducted after 2011) only half of men have been tested for HIV in the past 12 months.

The Lancet HIV: Tenfold increase in number of adolescents on HIV treatment in South Africa since 2010, but many still untreated
A new study of more than 700,000 one to 19-year olds being treated for HIV infection suggests a ten-fold increase in the number of adolescents aged 15 to 19 receiving HIV treatment in South Africa, according to results published in The Lancet HIV journal.

Starting HIV treatment in ERs may be key to ending HIV spread worldwide
In a follow-up study conducted in South Africa, Johns Hopkins Medicine researchers say they have evidence that hospital emergency departments (EDs) worldwide may be key strategic settings for curbing the spread of HIV infections in hard-to-reach populations if the EDs jump-start treatment and case management as well as diagnosis of the disease.

NIH HIV experts prioritize research to achieve sustained ART-free HIV remission
Achieving sustained remission of HIV without life-long antiretroviral therapy (ART) is a top HIV research priority, according to a new commentary in JAMA by experts at the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health.

The Lancet HIV: PrEP implementation is associated with a rapid decline in new HIV infections
Study from Australia is the first to evaluate a population-level roll-out of pre-exposure prophylaxis (PrEP) in men who have sex with men.

Researchers date 'hibernating' HIV strains, advancing BC's leadership in HIV cure research
Researchers have developed a novel way for dating 'hibernating' HIV strains, in an advancement for HIV cure research.

Read More: HIV News and HIV Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.